Postdoctoral Scientist

Dr Alison Burman

Group

Vesicular Disease Reference Laboratory

Expertise

Molecular Biology, Structural biology

Dr Alison Burman

Group

Vesicular Disease Reference Laboratory

Publications

Graham S P, McLean R K, Spencer A J, Belij-Rammerstorfer S, Wright D, Ulaszewska M, Edwards J C, Hayes J W P, Martini V, Thakur N, Conceicao C, Dietrich I, Shelton H, Waters R, Ludi A, Wilsden G, Browning C, Bialy D, Bhat S, Stevenson-Leggett P, Hollinghurst P, Gilbride C, Pulido D, Moffat K, Sharpe H, Allen E, Mioulet V, Chiu C, Newman J, Asfor A S, Burman A, Crossley S, Huo J, Owens R J, Carroll M, Hammond J A, Tchilian E, Bailey D, Charleston B, Gilbert S C, Tuthill T J, Lambe T (2020)

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Journal npj Vaccines

Read abstract

Shimmon G, Kotecha A, Ren J, Asfor A S, Newman J, Berryman S, Cottam E M, Gold S, Tuthill T J, King D P, Brocchi E, King A M Q, Owens R, Fry E E, Stuart D I, Burman A, Jackson T (2018)

Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays

Journal PLoS ONE

Read abstract

Shimmon G, Wood B A, Morris A, Mioulet V, Grazioli S, Brocchi E, Berryman S, Tuthill T, King D P, Burman A, Jackson T (2016)

Truncated bovine integrin alpha-v/beta-6 as a universal capture ligand for FMD diagnosis

Journal PLoS ONE

Read abstract

Gullberg M, Lohse L, Bøtner A, McInerney G M, Burman A, Jackson T, Polacek C, Belsham G J (2016)

A prime-boost vaccination strategy in cattle to prevent foot-and-mouth disease using a single-cycle alphavirus vector and empty capsid particles

Journal PLoS ONE

Read abstract

Pagination

Previous page
Page 1
Page 2
Next page

Articles

22 January 2021

Early animal studies by Pirbright and Oxford yield promising results for new potential COVID-19 vaccine

Studies carried out by The Pirbright Institute and the University of Oxford have shown that Oxford’s new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this…

23 June 2020

Studies at Pirbright demonstrate two doses of Oxford University’s COVID-19 vaccine boosts immune response in pigs

The Pirbright Institute, working in collaboration with the University of Oxford, have successfully shown that two doses of the ChAdOx1 nCoV-19 (AZD1222) vaccine produce a greater antibody response than a single dose in pigs. The emergence and subsequent spread of SARS-CoV-2 has caused a global…

26 September 2018

Engineering ‘Fab’ new ways of reducing animal use in foot-and-mouth disease diagnostics

A novel foot-and-mouth disease (FMD) diagnostic reagent has been developed by scientists at The Pirbright Institute. This has the potential to be used in FMD diagnostic tests, and will be significantly quicker to produce when compared to existing test reagents due to a simplified production…

24 August 2016

New method of diagnosing foot-and-mouth disease will use fewer small animals

Scientists at The Pirbright Institute, led by Gareth Shimmon, have found a new way of diagnosing foot-and-mouth disease (FMD) which is more cost effective and relies less on the use of small animals. FMD is a highly contagious viral disease that infects cloven-hoofed (two-toed) mammals such as…

12 October 2015

Designing foot-and-mouth disease synthetic vaccine design using computer simulations

Foot-and-mouth disease (FMD) is endemic in large parts of South America, Africa, The Middle East and Asia and is the most economically important infectious disease of livestock, affecting cattle, pigs, sheep, goats and other artiodactyl (even-toed) species. In endemic countries FMD affects national…

Contact

Title

Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Dr Alison Burman

Publications

Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19

Generation and characterisation of recombinant FMDV antibodies: Applications for advancing diagnostic and laboratory assays

Truncated bovine integrin alpha-v/beta-6 as a universal capture ligand for FMD diagnosis

A prime-boost vaccination strategy in cattle to prevent foot-and-mouth disease using a single-cycle alphavirus vector and empty capsid particles

Articles

Early animal studies by Pirbright and Oxford yield promising results for new potential COVID-19 vaccine

Studies at Pirbright demonstrate two doses of Oxford University’s COVID-19 vaccine boosts immune response in pigs

Engineering ‘Fab’ new ways of reducing animal use in foot-and-mouth disease diagnostics

New method of diagnosing foot-and-mouth disease will use fewer small animals

Designing foot-and-mouth disease synthetic vaccine design using computer simulations

Contact

A prime-boost vaccination strategy in cattle to prevent foot-and-mouth disease using a single-cycle alphavirus vector and empty capsid particles